Additional file 1: of Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach

Table S1. Sample information for the FISS transcriptome profiling. Each row corresponds to an RNA sample. Columns are as follows: sample name, the coded sample name used within this manuscript; biosample type, indicates whether the sample came from primary tissue or cultured cells; normal or cancer, distinguishes whether the sample is normal or cancerous; tissue type, gives the tissue subtype, such as sarcoma, skin, or muscle; Cat, the coded cat patient ID for this study; batch, the mRNA-seq batch number (see Methods); “#reads”, the total number of reads derived from the sample; “#uniquely mapped reads”, the number of reads that mapped to a unique location in the cat genome; %alignment, the percentage of the total number of reads that aligned to a unique location in the cat genome; #genes with non-zero count, the number of genes for which the count of aligned reads is greater than zero. (XLSX 11 kb)

表S1. FISS转录组谱分析样本信息表。每一行对应一个RNA样本，各列含义如下：样本名称，本文中使用的编码样本标识；生物样本类型，用于指明样本来源于原发组织还是体外培养细胞；样本性质，区分样本为正常组织或癌组织；组织亚型，给出具体组织类别，例如肉瘤、皮肤或肌肉；Cat，本研究中猫受试者的编码患者ID；测序批次，mRNA测序的批次编号（详见方法部分）；"#reads"，该样本的总读段数；"#uniquely mapped reads"，比对至猫基因组唯一位置的读段数；"%alignment"，比对至猫基因组唯一位置的读段占总读段的百分比；"#genes with non-zero count"，比对读段计数大于0的基因数量。（XLSX 11 kb）